89. リンパ脈管筋腫症 Lymphangioleiomyomatosis Clinical trials / Disease details

臨床試験数 : 39 / 薬物数 : 46 - (DrugBank : 20) / 標的遺伝子数 : 27 - 標的パスウェイ数 : 137

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03062943 (ClinicalTrials.gov)	October 2016	7/10/2016	A Study of Nintedanib for LymphAngioleioMyomatosis (LAM)	A Pilot Study of Nintedanib for LymphAngioleioMyomatosis (LAM)	Lymphangioleiomyomatosis	Drug: Nintedanib	IRCCS Multimedica	NULL	Recruiting	18 Years	N/A	Female	30	Phase 2	Italy
2	EUCTR2015-004919-20-IT (EUCTR)	09/03/2016	11/08/2016	A pilot study of nintedanib for lymphangioleiomyomatosis (LAM)	A pilot study of nintedanibfor lymphangioleiomyomatosis (LAM) - A pilot study of nintedanibfor lymph ...	Female subjects affected by Llymphangioleiomyomatosis (LAM) MedDRA version: 19.0;Level: PT;Classific ...	Trade Name: Ofev	MULTIMEDICA S.P.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: no	30	Phase 3	Italy

First Previous1Next Last